Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/25/23 16:30 | 8/24/23 | TSHA | Health | BioPrd | Biological Products, (No Diag | Alam Kamran | TX | O | CFO | S | -77 | 2.33 | 0 | -33 | -11 | 258 | D | ||||||||||||||
7/14/23 16:00 | 7/12/23 | TSHA | Health | BioPrd | Biological Products, (No Diag | Session R.A. II | TX | T | S.m | -61 | 0.7077 | 0 | -86 | -1 | 9,154 | D | |||||||||||||||
6/26/23 16:46 | 6/22/23 | TSHA | Health | BioPrd | Biological Products, (No Diag | Session R.A. II | TX | T | S.m | -20 | 0.7033 | 0 | -29 | 0 | 9,240 | D | |||||||||||||||
6/22/23 16:00 | 6/20/23 | TSHA | Health | BioPrd | Biological Products, (No Diag | Session R.A. II | TX | T | S.m | -308 | 0.7083 | 0 | -435 | -4 | 9,268 | D | |||||||||||||||
8/24/22 16:47 | 8/23/22 | TSHA | Health | BioPrd | Biological Products, (No Diag | Alam Kamran | TX | O | CFO | S | -12 | 3.47 | 0 | -3 | -1 | 266 | D | ||||||||||||||
8/22/22 20:05 | 8/18/22 | TSHA | Health | BioPrd | Biological Products, (No Diag | Alam Kamran | TX | O | CFO | S.m | -106 | 3.70 | 0 | -29 | -10 | 269 | D | ||||||||||||||
7/7/22 16:30 | 7/5/22 | TSHA | Health | BioPrd | Biological Products, (No Diag | Prasad Suyash | TX | O | CMO,Head | S.m | -48 | 3.70 | 0 | -13 | -2 | 531 | D | ||||||||||||||
7/1/22 18:55 | 6/29/22 | TSHA | Health | BioPrd | Biological Products, (No Diag | Prasad Suyash | TX | O | CMO,Head | S.m | -183 | 3.65 | 0 | -50 | -8 | 543 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |